",{"id":"SIGNIN"}).html('
Oramed Pharmaceuticals Inc., an Israeli drugmaker, announced on Thursday that a mid-stage trial for its oral insulin pill for the treatment of diabetes showed promising "therapeutic potential," BusinessWeek reported.